Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir in Recurrent Adenoid Cystic Carcinoma
NCT01065844Phase 2Completed
- Sponsor
- University of Iowa
- Start
- Oct 2009
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nelfinavir in adenoid cystic carcinoma (ACC), sponsored by University of Iowa. Started Oct 2009; status: completed.
02
Drugs
nelfinavir
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT01065844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065844.